Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneScan Europe was a pioneering biotechnology company specializing in molecular biological analysis and the detection of genetically modified organisms (GMOs). Based in Freiburg, Germany, the company developed and marketed DNA-based testing kits and provided analytical services to the food and agricultural industries. GeneScan was one of the first companies to offer standardized GMO testing globally, establishing a significant presence in Europe and the United States. In 2000, the company was acquired by Eurofins Scientific, where it became the foundation for Eurofins' global molecular biology and GMO testing business. Today, its legacy continues as a specialized division within the Eurofins network, providing high-precision analytical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneScan Europe.